STOCK TITAN

9,840-share Form 144 sale by Guardant Health (NASDAQ: GH)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Guardant Health reported a Form 144 notice relating to the proposed sale of Common stock. The filing lists 9,840 Common shares with a filing date of 04/16/2026 via Charles Schwab. The excerpt also notes a restricted stock lapse on 02/15/2026 and a reported sale of 348 shares by Musa Tariq on 03/18/2026.

Positive

  • None.

Negative

  • None.

Insights

Form 144 lists a proposed sale of Common shares and recent insider activity.

The filing shows a proposed disposition of 9,840 Common shares filed on 04/16/2026 through Charles Schwab, and records a restricted stock lapse dated 02/15/2026. It also records a prior sale of 348 shares by Musa Tariq on 03/18/2026.

These entries are routine reporting of planned or recent transactions; cash‑flow treatment and pricing details are not included in the provided excerpt. Subsequent SEC disclosures or broker confirmations would show execution details if the sale occurs.

Proposed sale listed 9,840 shares listed with Charles Schwab, filing date 04/16/2026
Recent insider sale 348 shares sale by Musa Tariq on 03/18/2026
Restricted stock lapse date 02/15/2026 Restricted Stock Lapse referenced for Guardant Health
Form 144 regulatory
"Filer Information | 144: Filer Information"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
Restricted Stock Lapse financial
"Common | 02/15/2026 | Restricted Stock Lapse"
Equity Compensation financial
"02/15/2026 | Equity Compensation"
Equity compensation is pay given to employees, executives or contractors in the form of company ownership—such as stock, stock options or restricted shares—rather than just cash. It matters to investors because it can align workers' incentives with shareholders (like paying someone in slices of the same pie they help grow), but it also increases the number of shares outstanding and company expenses, affecting ownership percentages and earnings per share.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does Guardant Health's (GH) Form 144 disclose?

The Form 144 discloses a proposed sale of 9,840 Common shares filed on 04/16/2026. It also notes a restricted stock lapse on 02/15/2026 and a reported insider sale of 348 shares on 03/18/2026.

Who is listed as having sold shares recently for GH in this excerpt?

The excerpt lists Musa Tariq as having sold 348 shares on 03/18/2026. The filing shows this past three‑month sale separate from the Form 144 proposed sale.

Does the Form 144 show where the shares will be sold for GH?

The filing lists Charles Schwab & Co., Inc. as the broker/dealer for the proposed sale dated 04/16/2026. The excerpt does not include execution price or specific sale method details.

What is a 'restricted stock lapse' noted in the GH excerpt?

A restricted stock lapse dated 02/15/2026 indicates restricted shares became transferable on that date, commonly allowing subsequent sale or transfer under securities law and reporting requirements.